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Coeliac disease or gluten-induced enteropathy is one of the commonest chronic gastrointestinal disorders encountered in Great Britain and Western Europe, with an incidence ranging from 1:2600 to I: 300. 1 -' A definitive diagnosis can only be achieved by jejunal biopsy and demonstration of mucosal abnormality." This invasive procedure cannot, however, be undertaken in all patients presenting with symptoms compatible with coeliac disease. Several screening tests have, therefore, been suggested':" of which the n-xylose absorption test and erythrocyte folate concentration have been the most widely applied. Neither, however, is both highly sensitive and specific.':" A combination of these two tests using a parallel approach, requiring either test to be positive, would improve sensitivity and would have a very high negative predictive value. In this retrospective study we have compared the diagnostic value of erythrocyte folate with the n-xylose absorption test in relation to jejunal morphology in 28 patients suspected of suffering from coeliac disease and we have also examined the predictive value of the combined tests in screening patients with suspected coeliac disease before referral for jejunal biopsy.
SUBJECTS AND METHODS
All 28 patients who had both a n-xylose absorption test and an erythrocyte folate level measurement made and who also underwent jejunal biopsy in the investigation unit at St Luke's Hospital, Guildford, Surrey, during 1987-1988, were included in the study.
The n-xylose absorption test was performed after an overnight fast. The patient emptied his bladder and drank a solution containing 5 g of n-xylose in 200 ml water. Thereafter he was encouraged to drink as much water as was comfortable in order to ensure adequate urine flow. Urine was collected for 5 h and its xylose content Correspondence: Dr M H Labib.
was measured by the method of Roe and Rice." A total excretion of 1·1 g (23% of the given dose) was considered to be the lower limit of normal."
During the test a venous blood sample was collected for measurement of erythrocyte folate by radioassay (BIO-RAD Laboratories Ltd, Hertfordshire, UK). A value below 151 J.l.g/L (342 nmol/L) was considered abnormally low. Jejunal biopsy material was obtained with a Crosby capsule positioned under radiological control just beyond the duodenojejunal junction. The specimen was immersed in 10% formalsaline and sent to the laboratory for histological assessment.
CLASSIFICATION OF PATIENTS
Of the 28 patients examined, 13 (mean age 49·6 years; age range 21-73; sex distribution 9 female and 4 male patients) had an abnormal jejunal biopsy specimen consistent with a diagnosis of coeliac disease. Fifteen patients (mean age 44·7 years; age range: 21-72; sex distribution 7 female and 8 male patients) had a normal biopsy.
RESULTS
All 13 patients with a positive jejunal biopsy had abnormal results in one or both tests, 12 (92%) had abnormal urinary xylose excretion and II (85%) had low erythrocyte folate concentrations. In 10 patients (77%) both tests were abnormal. Of the 15 patients with a normal jejunal biopsy, 7 (47%) had abnormal urinary xylose excretion, but only one (7%) had a low erythrocyte folate concentration and her xylose excretion was normal.
Erythrocyte folate showed a sensitivity of85% and specificity of 93% for coeliac disease compared with 92% and 53%, respectively, for the n-xylose absorption test (Table I) . The predictive value when both tests were abnormal for the presence of a histologically demonstrable mucosal lesion was 100%; conversely, when both tests were normal the predictive value for absence of a histologically demonstrable mucosal lesion was 100% ( Table 2) . 
DISCUSSION
In this retrospective study, erythrocyte folate was found to be highly specific, but slightly less sensitive than the D-xylose absorption test for the presence of a histologically confirmatory biopsy in patients suspected clinically of suffering from coeliac disease. Combination of the two biochemical tests provided excellent prediction for the presence or absence of a mucosal lesion. In recent years, blind peroral jejunal biopsy using the Crosby capsule with fluoroscopic positioning or endoscopic biopsy of the duodenum under direct vision have become routine in many hospitals for patients in whom a diagnosis of coeliac disease has been entertained on clinical grounds alone. The first procedure is time consuming, requires close supervision and is unpleasant for the patient, while the second requires a one day admission to the hospital, intravenous sedation and is not without risks. These procedures are too expensive to be undertaken on all patients presenting with symptoms compatible with a diagnosis of coeliac disease and a screening test which is both highly sensitive and sufficiently specific to keep false positives to manageable proportions would help in reaching a decision as to which patients to refer for jejunal biopsy.
The D-xylose absorption test has been widely used as a screening test, but in recent years its sensitivity and specificity have been questioned. Liebman" found 20% false positive and 30% false negative values, while Siaden and Kumar! found rates of 17% and 21%, respectively. Measurement of serum xylose at I h, corrected for surface area, was said to improve the predictive value of the test, 13 but this was not confirmed and has led to the suggestion that the test should be abandoned as a screening test." Serum and erythrocyte folate concentrations are generally low in patients with coeliac disease,"? Our data show that measurement of erythrocyte folate concentration was more efficient (89%) than the D-xylose absorption test (71%) in correctly predicting the presence or absence of coeliac disease. When the two tests were combined, the predictive accuracy for coeliac disease was markedly improved. When both tests were normal the predictive accuracy for absence of coeliac disease was 100%, suggesting that the combination of a red cell folate assay and D-xylose absorption test is ideal for reducing to manageable proportions the number of patients, with symptoms compatible with a diagnosis of coeliac disease, who are subjected to jejunal biopsy. A larger prospective study is required to validate our conclusion that in patients with clinical suspicion of coeliac disease in whom both an erythrocyte folate assay and a n-xylose test are normal, jejunal biopsy IS not indicated.
